ProfileGDS4177 / 221957_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 84% 80% 78% 77% 79% 79% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated278.2784
GSM603099KU-812 non-treated217.0280
GSM603098KCL-22 Imatinib-treated182.5378
GSM603097KCL-22 non-treated171.3777
GSM603102JURL-MK1 Imatinib-treated191.4979
GSM603101JURL-MK1 non-treated185.1379